AF-DX 384
Tocris Bioscience, part of Bio-Techne | Catalog # 1345
Potent M2/M4 antagonist
Product Description
AF-DX 384 is a potent M2/M4 selective antagonist (pKi values are 8.22, 8.00, 7.51, 7.18 and 6.27 at human M2, M4, M1, M3 and M5 receptors respectively).Product Specifications
Molecular Weight
478.64
Formula
C27H38N6O2
Storage
Store at RT
Purity
≥98% (HPLC)
Chemical Name
N-[2-[2-[(Dipropylamino)methyl]-1-piperidinyl]ethyl]-5,6-dihydro-6-oxo-11H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide
CAS Number
118290-26-9
PubChem ID
119357
InChI Key
MZDYABXXPZNUCT-UHFFFAOYSA-N
SMILES
CCCN(CCC)CC1CCCCN1CCNC(=O)N1C2=C(C=CC=C2)C(=O)NC2=C1N=CC=C2
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 23.93 | 50 | |
| Ethanol | 4.79 | 10 |
Preparing Stock Solutions
for AF-DX 384
The following data is based on the product molecular weight 478.64
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 4.18 mL | 20.89 mL | 41.79 mL |
| 2.5 mM | 0.84 mL | 4.18 mL | 8.36 mL |
| 5 mM | 0.42 mL | 2.09 mL | 4.18 mL |
| 25 mM | 0.08 mL | 0.42 mL | 0.84 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Grailhe Regional changes in the cholinergic system in mice lacking monoamine A. Brain Res.Bull. 2009 PMID: 19111597
- Miller Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors. J.Pharmacol.Exp.Ther. 1991 PMID: 1941609
- Dopke AF-DX 384 binding in rabbit cingulate cortex: two site kinetics and section autoradiography. J.Pharmacol.Exp.Ther. 1995 PMID: 7616446
Product Specific Notices for AF-DX 384
For research use only
Loading...
Loading...